Brought to you by:
Powered by wagescape.com
Labor Market Pulse
WA NONMETROPOLITAN AREA Edition
Focus: LIFE SCI
4.9%
WA unemployment rate
Down from 5.0% in July, 2nd straight monthly decline
$118,235
Regulatory Affairs pay growth
Metro median, up moderately vs $104,000 national
$147,800
Biostatistician pay divergence
Metro down moderately vs $133,322 national, up moderately
+1.9%
WA life sciences employment growth
2024, vs -0.3% national decline
This Month's Takeaways
Metro advertised median for Regulatory Affairs Specialist sits at $118,235, up moderately while the national median of $104,000 stays stable. This divergence suggests nonmetro and regional Washington employers are bidding up scarce regulatory talent to compete with Seattle-area biotech, not simply tracking national inflation.
Metro median fell to $147,800 even as the national median rose to $133,322, narrowing a gap that typically favors Washington employers. Softening local demand for this role may reflect project-based hiring pullback or greater reliance on CRO-provided biostatistics rather than in-house headcount.
Both metro ($84,620) and national ($90,956) medians moved up significantly this month, consistent with sustained clinical trial activity despite broader layoff headlines in biopharma. Nonmetro employers running local trial sites should expect sharper competition for CRA talent against better-funded metro sponsors.
Metro median held stable at $57,200 while the national median dropped moderately to $47,402, widening the premium nonmetro Washington employers must pay. Persistent entry-level scarcity in rural labor markets may be pushing wages up locally even as national demand for the role softens.
Local Labor Conditions
Rural Washington labor markets remain constrained by statewide unemployment holding near 4.9% and a thinning pool of credentialed scientific and manufacturing talent, even as the state's life sciences sector grew headcount 1.9% in 2024 against a 0.3% national decline. Outside the Seattle and Spokane metro cores, nonmetro counties see less direct biotech investment but compete for the same regulatory, quality, and bioprocess talent pulled toward Seattle MSA pharma manufacturing R&D roles, which grew 60% year-over-year with median pay near $190,500.
Leadership & Talent Implications
Thin nonmetro labor supply raises the cost and timeline risk of building GMP or quality staff locally, reinforcing the case for routing specialized manufacturing and analytical work to established CDMOs like Spokane's Jubilant HollisterStier rather than standing up new internal capacity. Regulatory and CMC talent scarcity statewide means nonmetro employers competing against Seattle-area total compensation packages will struggle to retain mid-career staff without differentiated pay or remote/hybrid flexibility tied to metro-benchmarked roles. Consider reviewing whether nonmetro regulatory affairs and manufacturing compensation bands track Seattle MSA movement closely enough to prevent quiet attrition toward higher-paying urban employers.
Advertised Pay Indicators
| Role | P25 | Median | P75 | Local Trend | National | Nat. Trend |
|---|---|---|---|---|---|---|
| Research Scientist | — | — | — | — No data | $131,354 | ↑ Significant increase |
| Clinical Research Associate | $80,763 | $84,620 | $100,523 | ↑ Significant increase | $90,956 | ↑ Significant increase |
| Lab Technician | $46,540 | $57,200 | $67,954 | → Stable | $47,402 | ↓ Moderate decline |
| Regulatory Affairs Specialist | $93,408 | $118,235 | $122,072 | ↑ Moderate increase | $104,000 | → Stable |
| Clinical Data Manager | $100,327 | $120,009 | $130,356 | → Stable | $123,031 | ↓ Moderate decline |
| Biostatistician | $111,745 | $147,800 | $158,319 | ↓ Moderate decline | $133,322 | ↑ Moderate increase |
| Validation Engineer | — | — | — | — No data | $108,377 | ↑ Moderate increase |
Some roles reflect state-level data where local metro sample size was insufficient.
Looking Ahead · Next 30–60 Days
Early indicator
Washington's 110 WARN notices in 2026 have skewed toward agriculture, fulfillment, and now healthcare, with MultiCare's 138-worker notice in September signaling spillover risk into nonmetro health systems that compete for the same clinical and lab talent pool.
Worth watching
Statewide unemployment has ticked down two consecutive months to 4.9%, but nonmetro counties typically lag state recovery; watch October county-level data (due ~October 20) for whether rural labor supply is actually loosening or merely tracking a statewide statistical improvement.
Emerging pressure point
CDMO hiring at Jubilant HollisterStier and continued Seattle MSA manufacturing R&D growth (60% YoY) may pull nonmetro quality and manufacturing staff toward metro employers offering higher advertised pay, accelerating build-vs-outsource decisions for nonmetro facilities.
Potential inflection point
National biopharma layoffs (BioMarin, Bristol Myers) alongside 64% of surveyed biopharma orgs still actively recruiting suggests displaced specialized talent may surface in regional candidate pools; nonmetro employers should monitor whether this eases regulatory and CMC scarcity locally.
WageScape Member Benefit
Your Pulse covers one metro and one function or industry. Add coverage if you want to see the latest intelligence for other markets, industries, or functions.
Pulse Plus
3 metro reports
$149/year
Pulse Pro
10 metro reports
$349/year
Enterprise
10+ markets
Contact us
WageTrak · 15% Member Discount
On-demand advertised pay data across thousands of job titles, all metro areas, full percentile coverage, and monthly updates. Use code WAGESCAPE15 at wagetrak.com.
Forwarded This Briefing?
Receive your own personalized monthly briefing, filtered to your local market. Scan to enroll below.